Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldman L, Blaney DJ, Kindel DJ, Franke EK. Effect of the laser beam on the skin: preliminary report. J Invest Dermatol. 1963;40:121-122.
Goldman L, Wilson RG, Hornby P, Meyer RG. Radiation from a Q-switched ruby laser: effect of repeated impacts of power output of 10 megawatts on a tattoo of man. J Invest Dermatol. 1965;44:69-71.
Ohshiro T, Maruyama Y. The ruby and argon lasers in the treatment of naevi. Ann Acad Med. 1983;12:388-395.
Dover JS, Smoller BR, Stein RS, et al. Low-fluence carbon dioxide laser irradiation of lentigines. Arch Dermatol. 1988;124:1219-1224.
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.
Polla LL, Margolis RJ, Dover JS, et al. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol. 1987;89:281-286.
Levins PC, Anderson RR. Q-switched ruby laser for the treatment of pigmented lesions and tattoos. Clin Dermatol. 1995;13:75-79.
Taylor CR, Anderson RR, Gange RW, et al. Light and electron microscopic analysis of tattoos treated by Q-switched ruby laser. J Invest Dermatol. 1991;97:131-136.
Ara G, Anderson RR, Mandel KG, et al. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells. Lasers Surg Med. 1990;10:52-59.
Dover JS, Margolis RJ, Polla LL, et al. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses. Arch Dermatol. 1989;125:43-49.
Ardnt KA, Dover JS, Olbricht SM. Lasers in Cutaneous and Aesthetic Surgery. Philadelphia: Lippincott-Raven; 1997.
Kossida T, Farinelli W, Flotte T, et al. Mechanism of immediate whitening during tattoo Removal. Lasers Surg Med. 2006;18:70.
Margolis RJ, Dover JS, Polla LL, et al. Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med. 1989;9:389-397.
Anderson RR, Margolis RJ, Watenabe S, et al. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989;93:28-32.
Hruza GJ, Dover JS, Flotte TJ, et al. Q-switched ruby laser irradiation of normal human skin. Arch Dermatol. 1991;127:1799-1805.
Murphy GF, Shepard RS, Paul BS, et al. Organelle-specific injury to melanin-containing cells in human skin by pulsed laser irradiation. Lab Invest. 1983;49:680-685.
Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77:13-19.
Sherwood KA, Murray S, Kurban AK, Tan OT. Effect of wavelength on cutaneous pigment using pulsed irradiation. J Invest Dermatol. 1989;92:717-720.
Nakamura Y, Hossain M, Hirayama K, Matsumoto K. A clinical study on the removal of gingival melanin pigmentation with the CO2 laser. Lasers Surg Med. 1999;25:140-147.
Vikramaditya P, Bedi MS, et al. The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing. Lasers Surg Med. 2007;39:145-155.
Ross EV, Ladin Z, Kreindel M, Dierickx C. Theoretical considerations in laser hair removal. Dermatol Clin. 1999;17:333-355.
Kono T, Manstein D, Chan HH. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med. 2006;38(2):94-97.
Ueda S, Imayama S. Normal-mode ruby laser for treating congenital nevi. Arch Dermatol. 1997;133:355-359.
Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol. 1993;32:908-912.
Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium:yttrium-aluminum-garnet laser. J Dermatol Surg Oncol. 1994;20:795-800.
Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. Arch Dermatol. 1994;130:1515-1519.
Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300 nsecond pulse and 510 nm wavelength. J Dermatol Surg Oncol. 1993;18:341-347.
Ashinoff R, Geronemus RG. Q-switched ruby laser treatment of labial lentigos. J Am Acad Dermatol. 1992;27:809-811.
Gupta G, MacKay IR, MacKie RM. Q-switched ruby laser in the treatment of labial melanotic macules. Lasers Surg Med. 1999;25:219-222.
Yung-Tsai L, Kao-Chia Y. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999;25:202-204.
Todd M, Rallis T, Hata T. A comparison of three lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol. 2000;50:536-540.
Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4:35-38.
Dover J et al. Adjunctive use of topical aminolevulinic acid with intense pulsed light in the treatment of photoaging. J Am Acad Dermatol. 2005;52:795-803.
Gold MH et al. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg. 2006;32(6):795-801.
Tekin M, Bodurtha JN, Riccardi VM. Café au lait spots: the pediatrician’s perspective. Pediatr Rev. 2001;22:82-90.
Grossman MC, Anderson RR, Farinelli W, et al. Treatment of cafe au lait macules with lasers: a clinicopathologic correlation. Arch Dermatol. 1995;131:1416-1420.
Alster TS. Complete elimination of large cafe-au-lait birthmarks by the 510-nm pulsed dye laser. Plast Reconstr Surg. 1995;96:1660.
Alora MB, Arndt KA. Successful treatment of a cafe-au-lait macule with the erbium:YAG laser. J Am Acad Dermatol. 2001;45(4):566-568.
Goldberg DJ. Benign pigmented lesions of the skin. J Dermatol Surg Oncol. 1993;19:376-379.
Rosio TJ. Techniques for tattoo removal. In: Wheeland RG, ed. Cutaneous Surgery. Philadelphia: WB Saunders; 1994:982-997.
Kobayashi T. Microsurgical treatment of nevus of Ota. J Dermatol Surg Oncol. 1991;17:936-941.
Clabaugh WA. Tattoo removal by superficial dermabrasion: five year experience. Plast Reconstr Surg. 1975;55:401-405.
Koerber WA, Price NM. Salabrasion of tattoos: a correlation of the clinical and histological results. Arch Dermatol. 1978;114:884-888.
Dvir E, Hirshowitz B. Tattoo removal by cryosurgery. Plast Reconstr Surg. 1980;66:373-378.
Cosman B, Apfelberg DB, Drucker D. An effective cosmetic treatment for Ota’s nevus. Ann Plast Surg. 1989;22:36-42.
Reid R, Muller S. Tattoo removal by CO2 laser dermabrasion. Plast Reconstr Surg. 1980;65:717-728.
van Leeuwen RL, Dekker SW, Byers HR, et al. Modulation of α4β1 and α5β1 integrin expression: heterogenous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melanoma cells in vitro. Lasers Surg Med. 1996;18:63-71.
Chan HH, Xiang K, Leung L, et al. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p161nk4a on melanoma cell lines. Lasers Surg Med. 2003;32(2):88-93.
Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197:71-73.
Grevelink JM, van Leeuwen RL, Anderson RR, Byers R. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol. 1997;133:349-353.
Goldberg DJ, Zeichner JA, Hodulik SG, et al. Q-switched laser irradiation of pigmented nevi: analysis of markers for malignant transformation. Lasers Surg Med. 2006;18:18.
Vibhagool C, Byers R, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol. 1997;36:738-741.
Rosenbach A, Williams CM, Alster TS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol Surg. 1997;23:239-245.
Duke D, Byers R, Sober AJ, et al. Treatment of benign and atypical nevi with the normal-mode ruby laser and the Q-switched ruby laser: clinical improvement but failure to completely eliminate nevomelanocytes. Arch Dermatol. 1999;135:290-296.
Baba M, Bal N. Efficacy and safety of the short-pulse erbium:YAG laser in the treatment of acquired melanocytic nevi. Dermatol Surg. 2006;32:256-260.
Milgraum SS, Cohen ME, Auletta MJ. Treatment of blue nevi with the Q-switched ruby laser. J Am Acad Dermatol. 1995;32:307-310.
Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med. 1994;331:1745-1750.
Imayama S, Ueda S. Long- and short-term histological observations of congenital nevi treated with the normal-mode ruby laser. Arch Dermatol. 1999;135:1211-1218.
Helsing P, Mork G, Sveen B. Ruby laser treatment of congenital melanocytic nevi – a pessimistic view. Acta Derm Venereol. 2006;86(3):235-237.
Arndt KA. Argon laser treatment of lentigo maligna. J Am Acad Dermatol. 1984;10:953-957.
Kopera D. Treatment of lentigo maligna with the carbon dioxide laser. Arch Dermatol. 1995;131:735-736.
Thissen M, Westerhof W. Lentigo maligna treated with ruby laser. Acta Derm Venereol. 1997;77:163.
Arndt KA. New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. J Am Acad Dermatol. 1986;14:1092.
Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.
Hidano A, Kajama H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol. 1967;95:187-195.
Jay B. Malignant melanoma of the orbit in a case of oculodermal melanocytosis (nevus of Ota). Br J Ophthalmol. 1965;49:359.
Geronemus RG. Q-switched ruby laser therapy of nevus of Ota. Arch Dermatol. 1992;128:1618-1622.
Lowe NJ, Wieder JM, Sawcer D, et al. Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser. J Am Acad Dermatol. 1993;29:997-1001.
Taylor CR, Flotte TJ, Gange W, Anderson RR. Treatment of nevus of Ota by Q-switched ruby laser. J Am Acad Dermatol. 1994;30:743-751.
Chang CJ, Nelson JS, Achauer BM. Q-switched ruby laser treatment of oculodermal melanosis (nevus of Ota). Plast Reconstr Surg. 1996;98:784-790.
Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg. 1995;21:592-596.
Lam AY et al. A retrospective study on the efficacy and complications of Q-switched alexandretie laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg. 2001;27(11):937-942.
Manuskiatti W et al. Treatment of acquired bilateral nevus of Ota-like macules (Hori’s nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol. 2003;48(4):584-591.
Polnikorn N et al. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg. 2000;26(5):477-480.
Manuskiatte W, Sivayathorn A, Leelaudomlipi P, Fitzpatrick RE. Treatment of acquired bilateral nevua of Ota-like maculess (Hori’s nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol. 2003;48(4):584-591.
Manuskiatti W et al. Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation after Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota-like macules. Arch Dermatol. 2007;143(9):1139-1143.
Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20:592-597.
Nouri K, Bowes L, Chartier T, et al. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999;25:494-497.
Manaloto RMP, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121-123.
Narurkar VA. Skin rejuvenation with microthermal fractional photothermolysis. Dermatol Ther. 2007;20:S10-S13.
Tannous Z, Astner S. Utilizing fractional resurfacing in the treatment of therapy resistant melasma. J Cosmet Laser Ther. 2005;7:39-43.
Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;32:1645-1650.
Lowe NJ, Wieder JM, Shorr N, et al. Infraorbital pigmented skin: preliminary observations of laser therapy. Dermatol Surg. 1995;21:767-770.
West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surg. 1998;24:615-616.
Manuskiatti W, Fitzpatrick RE, Goldman MP. Red ink tattoo reactions: successful treatment with the Q-switched 532 nm Nd:YAG laser. Dermatol Surg. 2000;26(2):113-120.
Dwyer CM, Cuddihy AM, Kerr REI, et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol. 1993;129:158-162.
Argenyi ZB, Finelli L, Bergfeld WF, et al. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy. J Cutan Pathol. 1987;14:176-180.
Collins P, Cotterill JA. Minocycline-induced pigmentation resolves after treatment with the Q-switched ruby laser. Br J Dermatol. 1996;135:317-319.
Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol. 1996;132:1251-1253.
Tsao H, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. 1996;132:1250-1251.
Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201-1204.
Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201-4.
Wilde JL, English JC, Finley EM. Minocycline-induced hyperpigmentation: treatment with the neodymium:YAG laser. Arch Dermatol. 1997;133:1344-1346.
Greve B, Schonermark MP, Raulin C. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser. Lasers Surg Med. 1998;22:223-227.
Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol. 1999;135:251-253.
Atkins DH, Fitzpatrick RE. Laser treatment of imipramine-induced hyperpigmentation. J Am Acad Dermatol. 2000;43(1):77-80.
Trotter MJ, Tron VA, Hollingdale J, Rivers JK. Localized chrysiasis induced by laser therapy. Arch Dermatol. 1995;131:1411-1414.
Yun PK, Arndt KA, Anderson RR. Q-switched laser-induced chrysiasis treated with long-pulsed laser. Arch Dermatol. 2002;138:1012-1014.
Baggish MS, Poiesz BJ, Joret D, et al. Presence of human immunodeficiency virus DNA in laser smoke. Lasers Surg Med. 1991;11:197-203.
Hirsch RJ, Anderson RR. Principles of Laser-Skin Interactions. In chapter 136, page 2148 in: Dermatology (ed.) Bolognia JL, Jorizzo JL, and Rapini RP. 1st edition, 2003.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Graber, E.M., Dover, J.S. (2011). Lasers and Lights for Treating Pigmented Lesions. In: Nouri, K. (eds) Lasers in Dermatology and Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-281-0_6
Download citation
DOI: https://doi.org/10.1007/978-0-85729-281-0_6
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-280-3
Online ISBN: 978-0-85729-281-0
eBook Packages: MedicineMedicine (R0)